Contents Pages by Subject


Article Image News Link • Global by Tyler Durdan

A UK-based drugmaker has agreed to pay a record $1.4 billion settlement to the US government in order to end criminal and civil probes into allegations of illegal marketing of opioid addiction treatment medication, according to the Justice Department